European Heart Journal Advance Access originally published online on November 22, 2006
European Heart Journal 2006 27(24):3073; doi:10.1093/eurheartj/ehl383
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy
Cardiology Department
The Heart Hospital
1618 Westmoreland Street
London W1G 8PH
UK
Tel: +44-207 573 8888
Fax: +44-207 573 8838
E-mail address: pelliott@doctors.org.uk
Servicio de Cardiologia
Hospital Virgen de la Arrixaca
Murcia
Spain
Cardiology Department
The Heart Hospital
London
UK
Cardiology Department
The Heart Hospital
London
UK
| The first 10% of the full text of this article appears below. |
We thank Maron et al. for their editorial on our paper.1,2
Hypertrophic cardiomyopathy (HCM) is a capricious disorder, characterized by heterogeneity at all levels. Together with its relative rarity, this has resulted in a dearth of evidence-based practice. The authors suggest that cardiologists rely on guidance from a few major centres
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. A. Nishimura and S. R. Ommen Hypertrophic Cardiomyopathy, Sudden Death, and Implantable Cardiac Defibrillators: How Low the Bar? JAMA, July 25, 2007; 298(4): 452 - 454. [Full Text] [PDF] |
||||
